Jiangsu Hengrui Pharmaceuticals intends to utilize the funding elevated from the IPO for professional tests and growth of producing centers.
发布者:BY IDA JORGENSEN,转转请注明出处:https://robotalks.cn/asian-pharma-company-with-ambitions-to-compete-in-obesity-market-reaches-ipo-in-hong-kong/